Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Acylcarnitine: Useful biomarker for early diagnosis of hepatocellular carcinoma in non-steatohepatitis patients.

Takaya H, Namisaki T, Kitade M, Shimozato N, Kaji K, Tsuji Y, Nakanishi K, Noguchi R, Fujinaga Y, Sawada Y, Saikawa S, Sato S, Kawaratani H, Moriya K, Akahane T, Yoshiji H.

World J Gastrointest Oncol. 2019 Oct 15;11(10):887-897. doi: 10.4251/wjgo.v11.i10.887.

2.

Effectiveness of Lusutrombopag in Patients with Mild to Moderate Thrombocytopenia.

Tsuji Y, Kawaratani H, Ishida K, Kaya D, Kubo T, Fujinaga Y, Sawada Y, Takaya H, Shimozato N, Kaji K, Namisaki T, Moriya K, Akahane T, Yoshiji H.

Dig Dis. 2019 Oct 25:1-6. doi: 10.1159/000504044. [Epub ahead of print]

PMID:
31655803
3.

VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma.

Takaya H, Namisaki T, Kitade M, Kaji K, Nakanishi K, Tsuji Y, Shimozato N, Moriya K, Seki K, Sawada Y, Saikawa S, Sato S, Kawaratani H, Akahane T, Noguchi R, Matsumoto M, Yoshiji H.

BMC Gastroenterol. 2019 Oct 21;19(1):167. doi: 10.1186/s12876-019-1082-1.

4.

TGR5 Activation Modulates an Inhibitory Effect on Liver Fibrosis Development Mediated by Anagliptin in Diabetic Rats.

Kaya D, Kaji K, Tsuji Y, Yamashita S, Kitagawa K, Ozutsumi T, Fujinaga Y, Takaya H, Kawaratani H, Moriya K, Namisaki T, Akahane T, Yoshiji H.

Cells. 2019 Sep 26;8(10). pii: E1153. doi: 10.3390/cells8101153.

5.

Combined effect of a farnesoid X receptor agonist and dipeptidyl peptidase-4 inhibitor on hepatic fibrosis.

Shimozato N, Namisaki T, Kaji K, Kitade M, Okura Y, Sato S, Moriya K, Seki K, Kawaratani H, Takaya H, Sawada Y, Saikawa S, Nakanishi K, Furukawa M, Fujinaga Y, Kubo T, Asada K, Kitagawa K, Tsuji Y, Kaya D, Ozutsumi T, Akahane T, Mitoro A, Yoshiji H.

Hepatol Res. 2019 Oct;49(10):1147-1161. doi: 10.1111/hepr.13385. Epub 2019 Jul 15.

PMID:
31177586
6.

Identification of clinical risk factors for histological progression of primary biliary cholangitis.

Fujinaga Y, Namisaki T, Moriya K, Kitade M, Kawaratani H, Shimozato N, Kaji K, Takaya H, Sawada Y, Seki K, Akahane T, Okura Y, Sato S, Saikawa S, Nakanishi K, Kubo T, Furukawa M, Kitagawa K, Ozutsumi T, Tsuji Y, Kaya D, Mashitani T, Ishida K, Ogawa H, Takagi H, Noguchi R, Mitoro A, Yamao J, Yoshiji H.

Hepatol Res. 2019 Sep;49(9):1015-1025. doi: 10.1111/hepr.13355. Epub 2019 Jun 14.

PMID:
31021038
7.

Blocking development of liver fibrosis augments hepatic progenitor cell-derived liver regeneration in a mouse chronic liver injury model.

Kitade M, Kaji K, Nishimura N, Seki K, Nakanishi K, Tsuji Y, Sato S, Saikawa S, Takaya H, Kawaratani H, Namisaki T, Moriya K, Mitoro A, Yoshiji H.

Hepatol Res. 2019 Sep;49(9):1034-1045. doi: 10.1111/hepr.13351. Epub 2019 May 29.

PMID:
30989766
8.

Socially Anxious Tendencies Affect Impressions of Others' Positive and Negative Emotional Gazes.

Tsuji Y, Shimada S.

Front Psychol. 2018 Nov 1;9:2111. doi: 10.3389/fpsyg.2018.02111. eCollection 2018.

9.

von Willebrand factor is a useful biomarker for liver fibrosis and prediction of hepatocellular carcinoma development in patients with hepatitis B and C.

Takaya H, Kawaratani H, Tsuji Y, Nakanishi K, Saikawa S, Sato S, Sawada Y, Kaji K, Okura Y, Shimozato N, Kitade M, Akahane T, Moriya K, Namisaki T, Mitoro A, Matsumoto M, Fukui H, Yoshiji H.

United European Gastroenterol J. 2018 Nov;6(9):1401-1409. doi: 10.1177/2050640618779660. Epub 2018 May 25.

10.

Efficacy and tolerability of interferon-free regimen for patients with genotype-1 HCV infection.

Takeda K, Noguchi R, Namisaki T, Moriya K, Akahane T, Kitade M, Kawaratani H, Shimozato N, Kaji K, Takaya H, Sawada Y, Seki K, Fujinaga Y, Tsuji Y, Kubo T, Sato S, Saikawa S, Nakanishi K, Furukawa M, Kitagawa K, Ozutsumi T, Kaya D, Mitoro A, Mashitani T, Okura Y, Yamao J, Yoshiji H.

Exp Ther Med. 2018 Sep;16(3):2743-2750. doi: 10.3892/etm.2018.6481. Epub 2018 Jul 19.

11.

Proton pump inhibitor therapy does not increase serum endotoxin activity in patients with cirrhosis.

Okura Y, Namisaki T, Sato S, Moriya K, Akahane T, Kitade M, Kawaratani H, Kaji K, Takaya H, Sawada Y, Shimozato N, Seki K, Saikawa S, Nakanishi K, Furukawa M, Fujinaga Y, Kubo T, Kaya D, Tsuji Y, Ozutsumi T, Kitagawa K, Mashitani T, Ogawa H, Ishida K, Mitoro A, Yamao J, Yoshiji H.

Hepatol Res. 2019 Feb;49(2):232-238. doi: 10.1111/hepr.13249. Epub 2018 Oct 9.

PMID:
30198141
12.

Pitfalls in the management of congenital tracheal stenosis: is conservative management feasible?

Usui Y, Ono S, Baba K, Tsuji Y.

Pediatr Surg Int. 2018 Oct;34(10):1035-1040. doi: 10.1007/s00383-018-4329-y. Epub 2018 Aug 11.

PMID:
30099581
13.

Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on hepatic fibrosis.

Namisaki T, Moriya K, Kitade M, Takeda K, Kaji K, Okura Y, Shimozato N, Sato S, Nishimura N, Seki K, Kawaratani H, Takaya H, Sawada Y, Akahane T, Saikawa S, Nakanishi K, Kubo T, Furukawa M, Noguchi R, Asada K, Kitagawa K, Ozutsumi T, Tsuji Y, Kaya D, Fujinaga Y, Yoshiji H.

Hepatol Commun. 2017 Sep 19;1(9):928-945. doi: 10.1002/hep4.1104. eCollection 2017 Nov.

14.

Socially anxious tendencies affect neural processing of gaze perception.

Tsuji Y, Shimada S.

Brain Cogn. 2017 Nov;118:63-70. doi: 10.1016/j.bandc.2017.08.002. Epub 2017 Aug 8.

PMID:
28800428
15.

Endoscopic chemocauterization for pyriform sinus fistula in children.

Yanagisawa S, Oshio T, Kato M, Kano M, Tsuji Y, Morikawa Y.

Pediatr Int. 2017 Jul;59(7):807-811. doi: 10.1111/ped.13294.

PMID:
28387991
16.

Ammonia synthesis over Co-Mo alloy nanoparticle catalyst prepared via sodium naphthalenide-driven reduction.

Tsuji Y, Kitano M, Kishida K, Sasase M, Yokoyama T, Hara M, Hosono H.

Chem Commun (Camb). 2016 Dec 13;52(100):14369-14372.

PMID:
27853756
17.

A new paradigm of scarless abdominal surgery in children: transumbilical minimal incision surgery.

Tsuji Y, Maeda K, Ono S, Yanagisawa S, Baba K, Usui Y.

J Pediatr Surg. 2014 Nov;49(11):1605-9. doi: 10.1016/j.jpedsurg.2014.06.009. Epub 2014 Aug 27.

PMID:
25475803
18.

Surgical reconstruction and endoscopic pancreatic stent for traumatic pancreatic duct disruption.

Kawahara I, Maeda K, Ono S, Kawashima H, Deie R, Yanagisawa S, Baba K, Usui Y, Tsuji Y, Fukuta A, Sekine S.

Pediatr Surg Int. 2014 Sep;30(9):951-6. doi: 10.1007/s00383-014-3570-2. Epub 2014 Jul 29.

PMID:
25070690
19.

Balloon tracheoplasty as initial treatment for neonates with symptomatic congenital tracheal stenosis.

Ono S, Maeda K, Baba K, Usui Y, Tsuji Y, Kawahara I, Fukuta A, Sekine S.

Pediatr Surg Int. 2014 Sep;30(9):957-60. doi: 10.1007/s00383-014-3571-1. Epub 2014 Jul 27.

PMID:
25064230
20.

New operative strategy for refractory microcystic lymphangioma.

Ono S, Tsuji Y, Baba K, Usui Y, Yanagisawa S, Maeda K.

Surg Today. 2014 Jun;44(6):1184-7. doi: 10.1007/s00595-013-0806-z. Epub 2013 Nov 30.

PMID:
24292654

Supplemental Content

Loading ...
Support Center